(6-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyridin-3-yl)boronic acid, 95.0%, 10g

2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethanesulfonate potassium, 95.0%, 25g

[4-(Isopropylsulfonyl)phenyl]acetic acid, 95.0%, 500mg

4-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE, 95.0%, 10g

DAPI, min. 98%, for biochemistry, 25 mg, glass packaging

1,1,1,3,3,3-Hexamethyldisilazane>96.0%(GC)100mL

(S)-6-Fluorochroman-4-amine, 95.0%, 250mg

3,4-Dimethylpyrrolidinehydrochloride, 95+%, 1g

(4-(Hydrazinylmethyl)phenyl)methanol hydrochloride, 98%, 100mg

N-ethylcyclopropanamine, 95.0%, 1g

4-Bromo-3-fluoro-6-nitro-2-(tetrahydrofuran-2-yl)aniline, 98%, 1g

1-benzyl-N-[(3-methylthiophen-2-yl)methyl]piperidin-4-amine dihydrochloride, 95.0%, 2g

1,4-DIACRYLOYLPIPERAZINE, 95.0%, 10g